Abstract Background Antimicrobial resistance in Mycoplasma genitalium (MG), a cause of
urethritis, is a growing concern. Yet little is known about the geographic distribution of MG …

Background Mycoplasma genitalium (MG) causes symptomatic urethritis in men, and can
infect alone or together with other sexually transmitted infection (STI) agents. Methods The …

Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …

Background Mycoplasma genitalium (MG) causes urethritis, cervicitis and pelvic
inflammatory disease. The MG treatment failure rate using 1 g azithromycin at an Australian …

Background. Empirical antibiotic therapy for nongonococcal urethritis (NGU) and cervicitis is
aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which also commonly causes …

Background. We evaluated the impact of extended azithromycin (1.5 g over 5 days) on
selection of macrolide resistance and microbiological cure in men with Mycoplasma …

Background Mycoplasma genitalium (MG) infection is challenging to cure because of rising
antimicrobial resistance and limited treatment options. Methods This was a prospective …

Background Rising macrolide and quinolone resistance in Mycoplasma genitalium
necessitate new treatment approaches. We evaluated outcomes of sequential antimicrobial …

Objectives We determined the prevalence of macrolide and fluoroquinolone resistance-
associated mutations in Mycoplasma genitalium DNA specimens from men with non …

Background Mycoplasma genitalium was previously less common among men who have
sex with men (MSM) compared with men with only female partners (MSW) in men with …